0
Skip to Content
Affordable.Skin
Find Comparables
Shop
Resources
Contact
About
Affordable.Skin
Find Comparables
Shop
Resources
Contact
About
Find Comparables
Shop
Resources
Contact
About
Shop La Roche-Posay Effaclar K Plus Face Cream
61-GEpTuCnL.jpg Image 1 of 12
61-GEpTuCnL.jpg
81JJHuQ65+L.jpg Image 2 of 12
81JJHuQ65+L.jpg
819BSHMz2OL.jpg Image 3 of 12
819BSHMz2OL.jpg
51fzbDehccL.jpg Image 4 of 12
51fzbDehccL.jpg
61qYmUnzNTL.jpg Image 5 of 12
61qYmUnzNTL.jpg
714Yag-RFUL.jpg Image 6 of 12
714Yag-RFUL.jpg
81LdlrZFfFL.jpg Image 7 of 12
81LdlrZFfFL.jpg
715al+hxXwL.jpg Image 8 of 12
715al+hxXwL.jpg
71xANHO0lCL.jpg Image 9 of 12
71xANHO0lCL.jpg
41ZBR8W+0eL.jpg Image 10 of 12
41ZBR8W+0eL.jpg
311VDxXNPzL.jpg Image 11 of 12
311VDxXNPzL.jpg
51DioMbaq+L.jpg Image 12 of 12
51DioMbaq+L.jpg
61-GEpTuCnL.jpg
81JJHuQ65+L.jpg
819BSHMz2OL.jpg
51fzbDehccL.jpg
61qYmUnzNTL.jpg
714Yag-RFUL.jpg
81LdlrZFfFL.jpg
715al+hxXwL.jpg
71xANHO0lCL.jpg
41ZBR8W+0eL.jpg
311VDxXNPzL.jpg
51DioMbaq+L.jpg

La Roche-Posay Effaclar K Plus Face Cream

$0.01

Product Description

This skincare product is designed for adult imperfection-prone skin, particularly for women. It is well tolerated, allergy tested, and non-comedogenic, making it suitable for sensitive skin. The product has been tested on oily imperfection-prone skin to ensure its effectiveness.

Quantity:
Add To Cart

Product Description

This skincare product is designed for adult imperfection-prone skin, particularly for women. It is well tolerated, allergy tested, and non-comedogenic, making it suitable for sensitive skin. The product has been tested on oily imperfection-prone skin to ensure its effectiveness.

Product Description

This skincare product is designed for adult imperfection-prone skin, particularly for women. It is well tolerated, allergy tested, and non-comedogenic, making it suitable for sensitive skin. The product has been tested on oily imperfection-prone skin to ensure its effectiveness.

Affordable.Skin

Terms of Use

Privacy Policy

Sign up with your email address to receive news and updates.

Thank you!